FDA approves first mRNA flu vaccine
Summary
The U.S. Food and Drug Administration (FDA) approved the first mRNA flu vaccine made by Moderna. The vaccine is authorized for people aged 50 and older.Key Facts
- The new flu vaccine uses mRNA technology, which helps the body learn to fight the flu virus.
- It is the first flu vaccine of its kind to be approved in the United States.
- The vaccine is approved for two age groups: 50 to 64 years old and 65 years and older.
- Moderna will carry out a study after the vaccine is released to check how well it works in real-life use.
- The approval follows tests showing the vaccine is safe and effective for the approved age groups.
- The vaccine aims to improve flu protection, especially for older adults who are at higher risk.
- This technology is similar to that used in some COVID-19 vaccines.
- The FDA's approval means the vaccine can now be given to eligible people during flu season.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
